181 related articles for article (PubMed ID: 2109714)
1. Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.
Serreze DV; Leiter EH; Shultz LD
Diabetologia; 1990 Feb; 33(2):84-92. PubMed ID: 2109714
[TBL] [Abstract][Full Text] [Related]
2. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
Serreze DV; Leiter EH
J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
[TBL] [Abstract][Full Text] [Related]
3. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
[TBL] [Abstract][Full Text] [Related]
5. Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.
Mathews CE; Graser RT; Savinov A; Serreze DV; Leiter EH
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):235-40. PubMed ID: 11136257
[TBL] [Abstract][Full Text] [Related]
6. NOD marrow stem cells adoptively transfer diabetes to resistant (NOD x NON)F1 mice.
Serreze DV; Leiter EH; Worthen SM; Shultz LD
Diabetes; 1988 Feb; 37(2):252-5. PubMed ID: 3134263
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
Li H; Kaufman CL; Ildstad ST
Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet-specific T-cell clones from nonobese diabetic mice.
Haskins K; Portas M; Bergman B; Lafferty K; Bradley B
Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8000-4. PubMed ID: 2510155
[TBL] [Abstract][Full Text] [Related]
9. Mixed allogeneic chimerism achieved by lethal and nonlethal conditioning approaches induces donor-specific tolerance to simultaneous islet allografts.
Li H; Colson YL; Ildstad ST
Transplantation; 1995 Sep; 60(6):523-9. PubMed ID: 7570945
[TBL] [Abstract][Full Text] [Related]
10. Analyses of development of insulitogenic T lymphocytes in NOD mice by transplantation of bone marrow, thymus, and pancreas.
Ida T; Yasumizu R; Ohnishi Y; Honxue F; Oyaizu N; Than S; Sugiura K; Inaba MM; Kuzuya H; Makino S
Transplantation; 1990 May; 49(5):976-82. PubMed ID: 2186525
[TBL] [Abstract][Full Text] [Related]
11. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
LaFace DM; Peck AB
Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
[TBL] [Abstract][Full Text] [Related]
13. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.
Chan WF; Razavy H; Luo B; Shapiro AM; Anderson CC
J Immunol; 2008 Apr; 180(8):5177-86. PubMed ID: 18390699
[TBL] [Abstract][Full Text] [Related]
14. Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice.
Wicker LS; Miller BJ; Chai A; Terada M; Mullen Y
J Exp Med; 1988 Jun; 167(6):1801-10. PubMed ID: 3290380
[TBL] [Abstract][Full Text] [Related]
15. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy.
Wu T; Levay-Young B; Heuss N; Sozen H; Kirchhof N; Sutherland DE; Hering B; Guo Z
Transplantation; 2002 Jul; 74(1):22-7. PubMed ID: 12134094
[TBL] [Abstract][Full Text] [Related]
16. Islet destruction by the NOD mouse may be mediated by both MHC-restricted and nonrestricted mechanisms.
Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M
Transplant Proc; 1991 Feb; 23(1 Pt 1):743-4. PubMed ID: 1990674
[No Abstract] [Full Text] [Related]
17. In vivo activity of an islet-reactive T-cell clone.
Bradley BJ; Wang YY; Lafferty KJ; Haskins K
J Autoimmun; 1990 Aug; 3(4):449-56. PubMed ID: 1977404
[TBL] [Abstract][Full Text] [Related]
18. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
Jin MX; Engelstad K; Oluwole SF
Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
[TBL] [Abstract][Full Text] [Related]
19. Effect of H-2 compatibility in autoimmune destruction of islet allografts from B10 congenic lines to nonobese diabetic mice.
Clare-Salzler M; Mullen Y; Chai A; Stein E; Girman D; Lennartz K
Pancreas; 1994 Mar; 9(2):179-85. PubMed ID: 8190719
[TBL] [Abstract][Full Text] [Related]
20. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]